Get started
RocketTickers

Spero Therapeutics Announces Positive Topline Results from its P

Long
CBOE S&P 500 Buffer Protect Index Balanc (CBOE:SPRO)  
RocketTickers  
CBOE:SPRO   CBOE S&P 500 Buffer Protect Index Balanc
Beyond Technical Analysis
0
0
beyondta
SPRO: Spero Therapeutics, Inc.
2020-09-08 07:30:10
Spero Therapeutics Announces Positive Topline Results from its Phase 3 ADAPT-PO Clinical Trial of Oral Tebipenem HBr in Complicated Urinary Tract Infection and Acute Pyelonephritis
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.